Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Oncotarget|December 13, 2017
MerTK is a novel therapeutic target in gastric cancerJun Ho Yi, Jiryeon Jang, Jeonghee Cho, et al.
Translational Oncology|March 23, 2017
Development of Novel Patient-Derived Preclinical Models from Malignant Effusions in Patients with Tyrosine Kinase Inhibitor-Resistant Clear Cell Renal Cell CarcinomaJiryeon Jang, Oliver Rath, Julia Schueler, et al.
Oncotarget|January 26, 2017
Acquired resistance to LY2874455 in FGFR2-amplified gastric cancer through an emergence of novel FGFR2-ACSL5 fusionSun Young Kim, Taejin Ahn, Heejin Bang, et al.
International Journal of Cancer|August 27, 2014
HER2-positive gastric cancer with concomitant MET and/or EGFR overexpression: a distinct subset of patients for dual inhibition therapySang Yun Ha, Jeeyun Lee, Jiryeon Jang, et al.
Translational Oncology|June 9, 2016
Genomic Alterations in Biliary Tract Cancer Using Targeted SequencingKwai Han Yoo, Nayoung K D Kim, Woo Il Kwon, et al.
The Journal of Clinical Investigation|November 18, 2014
Preexisting oncogenic events impact trastuzumab sensitivity in ERBB2-amplified gastroesophageal adenocarcinomaJihun Kim, Cameron Fox, Shouyong Peng, et al.
Plos One|December 31, 2013
Exome sequencing identifies early gastric carcinoma as an early stage of advanced gastric cancerGuhyun Kang, Woo Cheol Hwang, In-Gu Do, et al.
Plos One|February 2, 2013
A novel proteomics-based clinical diagnostics technology identifies heterogeneity in activated signaling pathways in gastric cancersJeeyun Lee, Sung Kim, Phillip Kim, et al.
Oncotarget|February 25, 2016
Molecular characterization of colorectal cancer patients and concomitant patient-derived tumor cell establishmentHaa-Na Song, Chung Lee, Seung Tae Kim, et al.
Oncotarget|October 17, 2015
NTRK1 rearrangement in colorectal cancer patients: evidence for actionable target using patient-derived tumor cell lineSu Jin Lee, Gang Gary Li, Seung Tae Kim, et al.
Pageof 4